Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 01, 2015 4:06 AM ET

Healthcare Equipment and Supplies

Company Overview of Essilor of America, Inc.

Company Overview

Essilor of America, Inc. manufactures and distributes optical lenses in the United States. It offers progressive, no-glare, ophthalmic, and soft contact lenses; and optical supplies, coatings, and sun protection glasses to eye care practitioners and retail optical chains in the United States. The company also operates an optical laboratory network, which serves opticians, optometrists, and ophthalmologists in the United States. In addition, it offers education and training programs, and business management support services. The company offers its products through sales consultants and distributors. The company was founded in 1996 and is headquartered in Dallas, Texas. It has distribution cen...

13515 North Stemmons Freeway

Dallas, TX 75234

United States

Founded in 1996





Key Executives for Essilor of America, Inc.

Chief Financial Officer and Executive Vice President
President of Independent Distribution Division
President of Essilor Lab Group
Vice President of Legal and General Counsel
Compensation as of Fiscal Year 2015.

Essilor of America, Inc. Key Developments

Essilor of America Launches New Line of Varilux Progressive Lenses

Essilor of America announced a new range of Varilux® Progressive lenses to debut on February 3, 2015. The launch will be supported by an additional investment in Varilux consumer advertising, following successful efforts in 2014 that led to higher traffic on the new and more searches on the ECP locator. The additional investment is also a direct result of increased patient visits to independent ECP offices and an increase in sales. Varilux is the progressive lens for the correction of presbyopia, the most widespread vision problem in the world. The new range of Varilux lenses also feature W.A.V.E. Technology 2TM, Essilor's next-generation lens technology that identifies and manages distortions to deliver sharp vision at every distance, even in low light. Essilor will provide ECPs with comprehensive training and streamlined, patient-friendly messaging around the new designs, to facilitate selection of the best visual solution for patients.

Essilor of America Launches Varilux Comfort Enhanced Fit Digital Lenses

Essilor of America announced the launch of Varilux Comfort Enhanced Fit ™ digital lenses, a new personalized option within the Varilux ® Comfort ® lenses family that is easy to prescribe. The new Varilux Comfort Enhanced Fit digital lens is the latest version of the innovative lens design that is tested and approved by wearers. Nine out of ten eyeglass wearers have different frame wearing parameters outside the average values traditionally used to calculate lens design. Varilux Comfort Enhanced Fit digital lenses allow the lens design to be optimized through use of personalized frame wearing measurements. In addition, these lenses minimize unnatural head movement when reading, provide comfortable transitions at all distances, reduce peripheral distortion to expand visual fields throughout the lens, and offer design elements on both sides of the lens through Varilux DualOptixTM digital surfacing. Comfort Enhanced Fit digital lenses are easily dispensed using the current Visioffice ® System, as well as the new Visioffice ® 2 System, which features cutting-edge, digital measuring technology that will be available this month.

Essilor of America Partners with Transitions Optical to Launch Transitions Signature TM VII Lenses

Essilor of America is partnering with Transitions Optical to launch Transitions ® Signature TM VII lenses, a dark photochromic lenses with full indoor clarity. With this launch, Essilor introduces The Power of 3 initiatives which includes three innovative brands - Varilux ®, Crizal ® No-Glare, and Transitions Signature VII lenses, to provide the sharpest and most comfortable vision at every distance and light condition. With The Power of 3, patients receive maximized visual performance in one dynamic lens. Transitions Signature VII lenses feature a groundbreaking technology, Chromea7 TM, a new proprietary photochromic dye formulation that absorbs more light to allow the lenses to be more responsive to UV than ever. Transitions Signature VII lenses were developed as the result of a new proprietary testing methodology, Life360 TM, which includes live wearer analysis and real world testing in more than 200 real life conditions, in addition to the traditional laboratory measurements. The results are best possible products with a superior wearer’s experience. Moreover, eight out of ten clear lens wearers preferred Transitions Signature VII lenses to the visual experience of their regular clear lenses.

Similar Private Companies By Industry

Company Name Region
Pneumoflex Systems, LLC United States
HistoSonics, Inc. United States
Medical Equipment Company, Inc. United States
Collagen Matrix, Inc. United States
PDx BioTech United States

Recent Private Companies Transactions

July 30, 2015
Vision Source, L.P.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Essilor of America, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at